Cargando…

Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas

Our aim is to analyse the bone profile in adults with (non-functioning) adrenal incidentalomas (AIs), specifically addressing the impact of autonomous cortisol secretion (ACS). This narrative review, based on a PubMed search from inception to February 2023 (case reports, non-ACS, and other secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Trandafir, Alexandra-Ioana, Stanciu, Mihaela, Albu, Simona Elena, Stoian, Vasile Razvan, Ciofu, Irina, Persu, Cristian, Nistor, Claudiu, Carsote, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342680/
https://www.ncbi.nlm.nih.gov/pubmed/37445279
http://dx.doi.org/10.3390/jcm12134244
_version_ 1785072557234323456
author Trandafir, Alexandra-Ioana
Stanciu, Mihaela
Albu, Simona Elena
Stoian, Vasile Razvan
Ciofu, Irina
Persu, Cristian
Nistor, Claudiu
Carsote, Mara
author_facet Trandafir, Alexandra-Ioana
Stanciu, Mihaela
Albu, Simona Elena
Stoian, Vasile Razvan
Ciofu, Irina
Persu, Cristian
Nistor, Claudiu
Carsote, Mara
author_sort Trandafir, Alexandra-Ioana
collection PubMed
description Our aim is to analyse the bone profile in adults with (non-functioning) adrenal incidentalomas (AIs), specifically addressing the impact of autonomous cortisol secretion (ACS). This narrative review, based on a PubMed search from inception to February 2023 (case reports, non-ACS, and other secondary causes of osteoporosis were excluded), included 40 original studies, a total of 3046 patients with female prevalence (female:male ratio of 1921:1125), aged between 20.5 and 95.5 years old. This three decade-based analysis showed that 37 studies provided dual-energy X-ray absorptiometry (DXA) information; another five studies reports results on bone micro-architecture, including trabecular bone score (TBS), spinal deformity index, and high-resolution peripheral quantitative computed tomography; 20 cohorts included data on bone turnover markers (BTMs), while four longitudinal studies followed subjects between 1 and 10.5 years old (surgical versus non-adrenalectomy arms). Post-dexamethasone suppression test (DST) cortisol was inversely associated with bone mineral density (BMD). TBS predicted incidental vertebral fractures (VFx) regardless of BMD, being associated with post-DST cortisol independently of age and BMD. Low BTMs were identified in ACS, but not all studies agreed. An increased prevalence of ACS-related osteoporosis was confirmed in most studies (highest prevalence of 87.5%), as well as of VFx, including in pre-menopause (42.5%), post-menopause (78.6%), and male patients (72.7%) depending on the study, with a 10-fold increased incidental VFx risk up to a 12-fold increased risk after a 2-year follow-up. No specific medication against osteoporosis is indicated in ACS, but adrenalectomy (according to four studies) should be part of the long-term strategy. This bone profile case sample-based study (to our knowledge, one of the largest of its kind) showed that AIs, including the subgroup designated as having ACS, embraces a large panel of osseous complications. The level of evidence remains far from generous; there are still no homogenous results defining ACS and identifying skeletal involvement, which might be a consequence of different investigation clusters underling adrenal and bone assessments over time. However, bone status evaluations and associated therapy decisions remain an essential element of the management of adults with AIs-ACS.
format Online
Article
Text
id pubmed-10342680
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103426802023-07-14 Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas Trandafir, Alexandra-Ioana Stanciu, Mihaela Albu, Simona Elena Stoian, Vasile Razvan Ciofu, Irina Persu, Cristian Nistor, Claudiu Carsote, Mara J Clin Med Review Our aim is to analyse the bone profile in adults with (non-functioning) adrenal incidentalomas (AIs), specifically addressing the impact of autonomous cortisol secretion (ACS). This narrative review, based on a PubMed search from inception to February 2023 (case reports, non-ACS, and other secondary causes of osteoporosis were excluded), included 40 original studies, a total of 3046 patients with female prevalence (female:male ratio of 1921:1125), aged between 20.5 and 95.5 years old. This three decade-based analysis showed that 37 studies provided dual-energy X-ray absorptiometry (DXA) information; another five studies reports results on bone micro-architecture, including trabecular bone score (TBS), spinal deformity index, and high-resolution peripheral quantitative computed tomography; 20 cohorts included data on bone turnover markers (BTMs), while four longitudinal studies followed subjects between 1 and 10.5 years old (surgical versus non-adrenalectomy arms). Post-dexamethasone suppression test (DST) cortisol was inversely associated with bone mineral density (BMD). TBS predicted incidental vertebral fractures (VFx) regardless of BMD, being associated with post-DST cortisol independently of age and BMD. Low BTMs were identified in ACS, but not all studies agreed. An increased prevalence of ACS-related osteoporosis was confirmed in most studies (highest prevalence of 87.5%), as well as of VFx, including in pre-menopause (42.5%), post-menopause (78.6%), and male patients (72.7%) depending on the study, with a 10-fold increased incidental VFx risk up to a 12-fold increased risk after a 2-year follow-up. No specific medication against osteoporosis is indicated in ACS, but adrenalectomy (according to four studies) should be part of the long-term strategy. This bone profile case sample-based study (to our knowledge, one of the largest of its kind) showed that AIs, including the subgroup designated as having ACS, embraces a large panel of osseous complications. The level of evidence remains far from generous; there are still no homogenous results defining ACS and identifying skeletal involvement, which might be a consequence of different investigation clusters underling adrenal and bone assessments over time. However, bone status evaluations and associated therapy decisions remain an essential element of the management of adults with AIs-ACS. MDPI 2023-06-24 /pmc/articles/PMC10342680/ /pubmed/37445279 http://dx.doi.org/10.3390/jcm12134244 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Trandafir, Alexandra-Ioana
Stanciu, Mihaela
Albu, Simona Elena
Stoian, Vasile Razvan
Ciofu, Irina
Persu, Cristian
Nistor, Claudiu
Carsote, Mara
Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
title Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
title_full Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
title_fullStr Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
title_full_unstemmed Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
title_short Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
title_sort management of adrenal cortical adenomas: assessment of bone status in patients with (non-functioning) adrenal incidentalomas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342680/
https://www.ncbi.nlm.nih.gov/pubmed/37445279
http://dx.doi.org/10.3390/jcm12134244
work_keys_str_mv AT trandafiralexandraioana managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT stanciumihaela managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT albusimonaelena managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT stoianvasilerazvan managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT ciofuirina managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT persucristian managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT nistorclaudiu managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas
AT carsotemara managementofadrenalcorticaladenomasassessmentofbonestatusinpatientswithnonfunctioningadrenalincidentalomas